Drupal.behaviors.print = function(context) {window.print();window.close();}>
Myriad to Buy Back $100M in Shares
March 02, 2011
Myriad to Buy Back $100M in Shares
The latest buyback is the firm's third $100 million share repurchase program.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Myriad Expands Stock Repurchase Program
August 31, 2010 / GenomeWeb Daily News
Prostate Cancer MDx Competition Heating Up; New Data from Genomic Health, Myriad
May 15, 2013 / Pharmacogenomics Reporter
Myriad to Launch NGS MyRisk Hereditary Cancer Panel this Year, Replace Existing Tests by Mid-2015
May 15, 2013 / Clinical Sequencing News
Myriad's Investment in RainDance Totals $5M
May 9, 2013 / GenomeWeb Daily News
Myriad to Replace BRACAnalysis, Other Hereditary Cancer Tests with MyRisk Panel
May 9, 2013 / GenomeWeb Daily News